6/21/2005 12:30:18 PM ET


    SWISS MEDICA’S O24™ PAIN NEUTRALIZER ADDS NEW RETAILERS
      
    FOR IMMEDIATE RELEASE

    Stock Symbol: OTC BB: SWME
    June 21, 2005

    SWISS MEDICA’S O24™ PAIN NEUTRALIZER ADDS NEW RETAILERS

    Toronto, Ontario Canada – Swiss Medica Inc. (OTC BB: SWME) is pleased to announce that the Company’s
    flagship O24™ Pain Neutralizer product is now available in more major retailers in the United States and
    Canada. Currently, O24™ Pain Neutralizer can now be found in more than 13,000 stores throughout the United
    States and Canada. Retail store locators for O24™ Pain Neutralizer can be found on our web site: www.O24zone.
    com . Swiss Medica will continue its extensive and aggressive marketing, public relations, and sampling programs
    to support the increased national distribution for O24™.

    “We are excited to continue adding major pharmacies to our growing list of customers,” announced Tom Quinn,
    Executive Vice President. “O24™ is now available for the first time in major markets such as New England,
    Texas, and Florida, including important metropolitan areas, such as Boston, Dallas, Houston, Atlanta, Miami,
    Tampa, and Orlando.”

    Due to the corporate policies of some of our retail customers that do not allow for press releases, we have not
    named specific retailers in this press release and are referring our shareholders and other investors to our
    O24™ product website for updated retailers who are selling O24™ Pain Neutralizer.

    About Swiss Medica Inc.

    Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
    market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a
    world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
    visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.

    Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain
    relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by
    healthcare professionals in the United States, Canada and in Europe. O24™ is widely available throughout
    Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of
    pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and
    store locators for the nearest pharmacy.

    Swiss Medica also manufactures PMS Escape® which holds US Patent #’s 5760014 and 5612320. PMS
    Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce
    changes in mood and appetite that women experience during the premenstrual period. Customers can also visit
    www.pmsescape.com for additional information and ordering details.

    Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United
    States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
    statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
    transactions being contemplated, risks related to international sales and potential foreign currency exchange
    fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological
    changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's
    periodic reports filed with the United States Securities and Exchange Commission and other regulatory
    authorities.

    For more information, please contact:

    Swiss Medica Inc.
    Investor Relations Contact:
    David Jones
    (866) 485-4243
    djones@swissmedica.com